Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France
NCT ID: NCT02887781
Last Updated: 2024-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
150 participants
OBSERVATIONAL
2015-08-13
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Clinic-pathological Correlation of Basal Cell Carcinoma
NCT02825511
Lymphangioleiomyomatosis, a Study on Cathepsin K
NCT05323370
Clinical and Biological Study of Sub-pigmentation During Infantile Cystinosis
NCT00822250
Natural History of Pompe Disease
NCT03564561
Renal HYPODYSPLASIA : Genetic and Familial Assessment
NCT00925379
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient presenting with tuberous sclerosis complex combined with an angiomyolipoma or
* Patient presenting with tuberous sclerosis complex
* Patient not objecting to the study
Exclusion Criteria
8 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yannick LE MEUR, MD PhD
Role: STUDY_DIRECTOR
University Hospital, Brest
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Brest
Brest, , France
CHU Rennes
Rennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TSAR (RB 14.055)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.